PACS Group Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $5.5B+35.8% YoYTTM through 30 Jun 2026
Net Income $269.2M+382.7% YoYTTM through 30 Jun 2026
Free Cash Flow $298.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 8.0% |
| Operating Margin | 7.4% |
| Net Margin | 4.9% |
Returns
20.1%ROE
3.4%ROA
22.6%ROIC
Balance Sheet Health
Debt / Equity3.61x
Current Ratio1.07x
Net Debt$3.2B
Cash & Equivalents$164.5M
Quality Metrics
Altman Z-Score2.19
Piotroski F-Score6 / 9
FCF Margin5.4%
Rule of 4010.6
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $5.3B
Diluted EPS$1.71TTMFY2025: $1.22
Dividend
No dividend
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.